🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,911 results for “Pharma” Clear

  1. Cholic Acids

    Mirum Pharmaceuticals International B.V.

    Infantile Refsum's Disease

    phase 3 small molecule completed

    1 trial

  2. Cholic acid

    Mirum Pharmaceuticals International B.V.

    Inborn Errors of Bile Acid Synthesis

    phase 3 small molecule completed

    1 trial

  3. Cibinqo 100 mg film-coated tablets, Placebo for Abrocitinib 100mg tablet

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Moderate to severe atopic dermatitis

    phase 3 small molecule active

    1 trial

  4. Cidofovir, Brincidofovir

    Pharma Mar S.A.

    Adenovirus viremia

    phase 3 small molecule active

    1 trial

  5. Cilostazol-Elpen 100 mg Tabletten, Placebo de Cilostazol-Elpen 100mg, comprimé

    Pari Pharma GmbH

    Aneurysmal Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

  6. Cimzia 200 mg solution for injection in pre-filled syringe, SODIUM CHLORIDE

    Pari Pharma GmbH

    Adult women with recurrent implantation failures (RIF)

    phase 3 small molecule active

    1 trial

  7. Cinryze®

    Takeda Pharmaceuticals International AG

    Acute Antibody-Mediated Rejection (AMR)

    phase 3 mab terminated

    1 trial

  8. Cisplatin

    China SXT Pharmaceuticals

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

  9. Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Cisplatin 1 mg/ml Concentrate for Solution for Infusion

    Cancer Prevention Pharma (Ireland) Limited

    Advanced head and neck cancer

    phase 3 small molecule active

    1 trial

  10. Cisplatin Hikma 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Zipalertinib, Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Pemetrexed Fresenius Kabi 100 mg powder for concentrate for solution for infusion

    Taiho Pharma Netherlands B.V.

    Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

    phase 3 small molecule active

    1 trial

  11. Clascoterone

    Sunshine Biopharma

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  12. Class I or III Antiarrhythmic Medications

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    phase 3 small molecule completed

    1 trial

  13. Clifutinib

    Sunshine Biopharma

    Leukemia, Acute Myeloid (AML)

    phase 3 small molecule active

    1 trial

  14. Cohort 1: Lubiprostone Capsule, Fasted

    Takeda Pharmaceuticals International AG

    Healthy Volunteers

    phase 3 small molecule completed

    1 trial

  15. Combined use of TPO-RAs with low-dose anti-CD20 antibody

    China SXT Pharmaceuticals

    Immune Thrombocytopenia (ITP)

    phase 3 small molecule active

    1 trial

  16. Combipress 150 mg/5 mg επικαλυμμένα με λεπτό υμένιο δισκία, Combipress 150 mg/10 mg επικαλυμμένα με λεπτό υμένιο δισκία, Combipress 300 mg/10 mg επικαλυμμένα με λεπτό υμένιο δισκία, Combipress 300 mg/5 mg επικαλυμμένα με λεπτό υμένιο δισκία

    Pharma Mar S.A.

    Arterial Hypertension

    phase 3 small molecule active

    1 trial

  17. Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid

    China SXT Pharmaceuticals

    Acute Promyelocytic Leukaemia

    phase 3 small molecule active

    1 trial

  18. Conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule terminated

    1 trial

  19. Conjunctival Provocation Test Grass-Mix LETI 30 HEP/ml, Conjunctival Provocation Test Olea europaea LETI 30 HEP/ml, Depigoid DUO Grass-Mix/Olea (1000 DPP/ml + 1000 DPP/ml), PLACEBO (Depigoid): the placebo is the solvent used in the investigational medicinal products’ (IMP) formulation. The resulting product is a suspension.

    Pharma Mar S.A.

    Allergic rhinoconjunctivitis with or without asthma due to clinically relevant sensitisation to grass and olive pollen.

    phase 3 small molecule active

    1 trial

  20. Coronary Artery Bypass Graft with the use of CPB

    China SXT Pharmaceuticals

    the Efficacy and Safety of Off-pump CABG

    phase 3 other completed

    1 trial

  21. Coronary CTA

    China SXT Pharmaceuticals

    Coronary Artery Disease

    phase 3 other completed

    1 trial

  22. Coronary artery bypass grafting

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Failure

    phase 3 other completed

    1 trial

  23. Custirsen

    Teva Pharma GmbH

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  24. Cx601

    Takeda Pharmaceuticals International AG

    Crohn's Disease

    phase 3 other completed

    3 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources